Journal: Frontiers in Oncology
Article Title: Emodin inhibits colon cancer tumor growth by suppressing tumor cell glycolysis through inhibition of NAT10-mediated PGK1 ac4C modification
doi: 10.3389/fonc.2025.1575391
Figure Lengend Snippet: NAT10 knockdown suppressed PGK1 mRNA stability by inhibiting its ac4C modification. (A) The expression of NAT10 was measured by qPCR. (B) The protein levels of NAT10 were detected by western blot. (C) The expression of PGK1 was measured by qPCR. (D) The protein levels of PGK1 were detected by western blot. (E) The ac4C levels of HCT-116 and SW480 cells were detected by MeRIP. (F) The ac4C modification site of PGK1 was predicted using the PACES database. (G) The interaction between NAT10 and PGK1 was identified by RIP. (H) The luciferase activity of WT-PGK1 and MUT-PGK1 of HCT-116 cells. (I) The stability of PGK1 mRNA was measured by qPCR after HCT-116 cells treated with 5 μg/mL actinomycin D for 0, 4, 8, and 12 h. N = 3 per group. Data analysis was performed using student’s t-test (A, C, D, G) or ANOVA (F, H) .
Article Snippet: Extracellular acidification rate (ECAR) of HCT-116 and SW480 cells was measured using an ECAR fluorometric assay kit (Elabscience, Wuhan, China).
Techniques: Knockdown, Modification, Expressing, Western Blot, Luciferase, Activity Assay